Your browser doesn't support javascript.
loading
Challenges and opportunities in oncology drug development and clinical research in China.
Wang, Feng; Ruan, Dan-Yun; Xu, Rui-Hua.
Afiliação
  • Wang F; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University, Guangzhou 510060, P.R. China; Research Unit of Precision Diagnosis and Treatment for Gastrointestinal Cancer, Chinese Academy of Medical Sciences, Guangzhou 510060, P.R. China.
  • Ruan DY; Research Unit of Precision Diagnosis and Treatment for Gastrointestinal Cancer, Chinese Academy of Medical Sciences, Guangzhou 510060, P.R. China; Department of Clinical Research, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University, Guangzhou 510060, P.R. China.
  • Xu RH; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University, Guangzhou 510060, P.R. China; Research Unit of Precision Diagnosis and Treatment for Gastrointestinal Cancer, Chinese Academy of Medical Sciences, Guangzhou 510060, P.R. China. Electronic address: xurh@sysucc.org.cn.
Cell ; 187(7): 1578-1583, 2024 Mar 28.
Article em En | MEDLINE | ID: mdl-38552607
ABSTRACT
As one of the world's most populous countries, China bears a heavy burden and a broad spectrum of cancers, including unique types, providing a unique environment for drug research and development. In recent years, China has leapt forward in oncology drug development and clinical trials, presenting new opportunities and challenges.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Desenvolvimento de Medicamentos / Oncologia / Neoplasias / Antineoplásicos Limite: Humans País como assunto: Asia Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Desenvolvimento de Medicamentos / Oncologia / Neoplasias / Antineoplásicos Limite: Humans País como assunto: Asia Idioma: En Ano de publicação: 2024 Tipo de documento: Article